In the adenoma–carcinoma sequence, mutations in the APC gene are pivotal for tumor initiation and are frequently observed, while P53 mutations, often influenced by APC and KRAS mutations, mainly contribute to the progression from adenoma to carcinoma. This evidence concerns the gene KRAS and adenoma.